01 12Blake Cassels & Graydon LLP
02 4Janssen Inc.
03 16Blank
01 161256867
02 32135062
03 42175370
04 12194564
05 42352818
06 42406536
01 16Risperidone
02 16Blank
01 3Orally Disintegrating Tablet
02 12Powder for Injectable Prolonged-Release Suspension
03 1Solution
04 16Blank
01 162006-07-04
02 32013-05-03
03 42014-11-11
04 12015-07-04
05 42019-12-10
06 42021-04-19
Patent Expiration Date : 2015-07-04
Date Granted : 1998-01-27
Brand Name : RISPERDAL
Patent Number : 2194564
Filing Date : 1995-07-04
Strength per Unit : 1 mg / ml
Dosage Form : Solution
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2015-07-04
Date Granted : 1998-01-27
Patent Expiration Date : 2019-12-10
Date Granted : 2009-04-14
Brand Name : RISPERDAL CONSTA
Patent Number : 2352818
Filing Date : 1999-12-10
Strength per Unit : 25 mg / vial
Dosage Form : Powder for Injectable Prolonged-Release Suspension
Human Or VET : Human
Route of Administration : Intramuscular Injection
Patent Expiration Date : 2019-12-10
Date Granted : 2009-04-14
Patent Expiration Date : 2019-12-10
Date Granted : 2009-04-14
Brand Name : RISPERDAL CONSTA
Patent Number : 2352818
Filing Date : 1999-12-10
Strength per Unit : 37.5 mg / vial
Dosage Form : Powder for Injectable Prolonged-Release Suspension
Human Or VET : Human
Route of Administration : Intramuscular Injection
Patent Expiration Date : 2019-12-10
Date Granted : 2009-04-14
Patent Expiration Date : 2019-12-10
Date Granted : 2009-04-14
Brand Name : RISPERDAL CONSTA
Patent Number : 2352818
Filing Date : 1999-12-10
Strength per Unit : 50 mg / vial
Dosage Form : Powder for Injectable Prolonged-Release Suspension
Human Or VET : Human
Route of Administration : Intramuscular Injection
Patent Expiration Date : 2019-12-10
Date Granted : 2009-04-14
Patent Expiration Date : 2019-12-10
Date Granted : 2009-04-14
Brand Name : RISPERDAL CONSTA
Patent Number : 2352818
Filing Date : 1999-12-10
Strength per Unit : 12.5 mg / vial
Dosage Form : Powder for Injectable Prolonged-Release Suspension
Human Or VET : Human
Route of Administration : Intramuscular injection
Patent Expiration Date : 2019-12-10
Date Granted : 2009-04-14
Patent Expiration Date : 2013-05-03
Date Granted : 1999-05-25
Brand Name : RISPERDAL M-TAB
Patent Number : 2135062
Filing Date : 1993-05-03
Strength per Unit : 0.5 mg
Dosage Form : Orally Disintegrating Tablet
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2013-05-03
Date Granted : 1999-05-25
Patent Expiration Date : 2013-05-03
Date Granted : 1999-05-25
Brand Name : RISPERDAL M-TAB
Patent Number : 2135062
Filing Date : 1993-05-03
Strength per Unit : 1 mg
Dosage Form : Orally Disintegrating Tablet
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2013-05-03
Date Granted : 1999-05-25
Patent Expiration Date : 2013-05-03
Date Granted : 1999-05-25
Brand Name : RISPERDAL M-TAB
Patent Number : 2135062
Filing Date : 1993-05-03
Strength per Unit : 2 mg
Dosage Form : Orally Disintegrating Tablet
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2013-05-03
Date Granted : 1999-05-25
Patent Expiration Date : 2021-04-19
Date Granted : 2009-12-22
Brand Name : RISPERDAL CONSTA
Patent Number : 2406536
Filing Date : 2001-04-19
Strength per Unit : 25 mg / vial
Dosage Form : Powder for Injectable Prolonged-Release Suspension
Human Or VET : Human
Route of Administration : Intramuscular Injection
Patent Expiration Date : 2021-04-19
Date Granted : 2009-12-22
Patent Expiration Date : 2014-11-11
Date Granted : 2006-06-26
Brand Name : RISPERDAL CONSTA
Patent Number : 2175370
Filing Date : 1994-11-11
Strength per Unit : 25 mg / vial
Dosage Form : Powder for Injectable Prolonged-Release Suspension
Human Or VET : Human
Route of Administration : Intramuscular Injection
Patent Expiration Date : 2014-11-11
Date Granted : 2006-06-26
LOOKING FOR A SUPPLIER?
